Print

Trump expected to shift course on antitrust, stop Google breakup

Donald Trump will likely dial back some of the antitrust policies pursued under the administration of President Joe Biden, potentially including a bid to break up Alphabet’s Google over its dominance in online search, experts said.

Trump is expected to continue cases against Big Tech, several of which began in his first term, but his recent skepticism about a potential Google breakup highlights the power he will hold over how those cases are run.

“If you do that, are you going to destroy the company? What you can do without breaking it up is make sure it’s more fair,” he said at an event in Chicago in October.

The U.S. Department of Justice is currently pursuing two antimonopoly cases against Google – one over search and another over advertising technology, as well as a case against Apple. The U.S. Federal Trade Commission is suing Meta Platforms and Amazon.

The DOJ has laid out a range of potential remedies in the search case, including making Google divest parts of its business such as the Chrome Web browser and ending agreements that make it the default search engine on devices like Apple’s iPhone.

But the trial over those fixes will not happen until April 2025, with a final ruling likely in August. That gives Trump and the DOJ time to change course if they choose, said William Kovacic, a law professor at George Washington University.

“He is certainly in the position to control the DOJ’s disposition of the remedies phase,” said Kovacic, who chaired the Federal Trade Commission under then-president George W. Bush.

Trump is also likely to pull back on some policies that have irritated dealmakers under the Biden administration, attorneys said. One is a reluctance to settle with merging companies, which was previously common and let companies address competition problems that agencies raised about deals by taking actions like selling part of the business.

The FTC and DOJ would likely scrap merger review guidelines crafted under Biden, said Jon Dubrow, a partner at law firm McDermott Will & Emery.

“The 2023 merger guidelines were very hostile to mergers and acquisitions,” he said, echoing a view widely held on Wall Street.

The FTC’s ban on most noncompete clauses in employer-employee contracts could be more vulnerable to a lawsuit brought by the U.S. Chamber of Commerce, if the FTC votes not to defend it.

About 30 million people, or 20% of U.S. workers, have signed noncompetes, according to the FTC. The agency is currently appealing a court ruling that blocked the rule.

But such actions to dismantle the work of FTC Chair Lina Khan will depend on a Trump-appointed replacement being confirmed to give the bipartisan five-member commission a Republican majority.

Khan’s initiatives focused on what she saw as societal harms caused by unchecked corporate consolidation, drawing praise from both Democrats and some Republicans, including Vice President-elect JD Vance. But some in the business and legal communities have criticized her approach as too aggressive.

Trump is not expected to drastically curtail antitrust enforcement, however. A similar number of merger cases was brought under his first term as during the first two years of the Biden administration, according to an analysis by the Sheppard Mullin law firm.

(Reuters)

RELATED ARTICLES

4 hours ago | Fairfax Financial Holdings

Cabinet approves Rs 52,878 crore sale of 60.72% stake in IDBI Bank to Fairfax entity

The Cabinet Committee on Economic Affairs (CCEA) on Wednesday approved Canada-based Fairfax Financial Holdings Ltd. as the strategic buyer for a 60.72% stake in IDBI Bank for approximately ₹52,878.08 crore. The transaction comprises the sale of a ...

5 hours ago | Annual Meetings

Nirmala Sitharaman to Attend IMF-World Bank Annual Meetings in Bangkok

Union Finance and Corporate Affairs Minister Nirmala Sitharaman will visit Bangkok, Thailand, from October 14 to 18 to participate in the Annual Meetings of the International Monetary Fund (IMF) and the World Bank Group, along with meetings of G20 an...

5 hours ago | Benchmark equity indices ended lower

Sensex falls, Nifty slips below 22,650 as pharma, healthcare stocks drag

Benchmark equity indices ended lower on Wednesday, weighed down by losses in pharma and healthcare stocks, even as gains in information technology shares limited the decline. The Sensex declined 251.89 points, or 0.34 per cent, to close at 72,781.8...